RxDoctor Payments Data

Olivia Neal, NP

Adult Health · Brunswick, GANPI 1285973149

Payments from drug & device makers

$1,891in general payments, 2019–2025

Across 65 payments — averaging $29.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$565
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$490
  • Medtronic$216
  • Boston Scientific$150
  • Shockwave Medical, Inc$106
  • Boehringer Ingelheim$75
  • plus $289 from 9 others

What the payments were for

  • Food & beverage$1,87299%
  • Education$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,891 in reported general payments places this provider in the 75th percentile of 577 adult health providers in Georgia.

See all adult health providers in Georgia

Medicare billing

Part B allowed, 2024
$43,576
Medicare patients
378
Services billed
688

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban265$253,835
EntrestoSacubitril/Valsartan51$46,292
Repatha SureclickEvolocumab48$38,062
XareltoRivaroxaban20$20,274
BrilintaTicagrelor19$10,963
Bisoprolol Fumarate132$4,400
Ezetimibe117$3,595
Metoprolol Succinate223$3,291
Ranolazine ErRanolazine32$2,977
Losartan Potassium232$2,828
Potassium Chloride191$2,680
Rosuvastatin Calcium161$1,988
Atorvastatin Calcium227$1,973
Telmisartan51$1,711
Valsartan31$1,574

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$33$253,835265 claims
NovartisEntresto$27$46,29251 claims
Johnson & JohnsonXarelto$42$20,27420 claims
AstraZenecaBrilinta$48$10,96319 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 577 adult health providers in Georgia.

Other adult health in Brunswick

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →